Oct 23 (Reuters) – Britain’s medicines regulator on Friday approved Johnson & Johnson’s daily pill for adults and teenagers with moderate-to-severe plaque psoriasis, a skin condition causing red, scaly and often itchy or painful patches. Here are some details: • The Medicines and Healthcare products
Oct 23 (Reuters) – Bristol Myers Squibb and partner SystImmune said on Friday their experimental breast cancer treatment slowed disease progression compared to standard chemotherapy in a late-stage study. The drug, izalontamab brengitecan, reduced the risk of disease worsening or death by 59% in pat
Oct 23 (Reuters) – Indian drugmaker Torrent Pharmaceuticals reported a near 10% decline in second-quarter profit on Friday, as higher spending on research and development outpaced robust demand for chronic therapies in the country. • Consolidated net profit fell to 5.34 billion rupees for the quarte
Oct 23 (Reuters) – Revolution Medicines said on Friday its recently approved pancreatic cancer drug Rasonque improved overall survival in previously treated patients, regardless of whether they carried an RAS mutation that drives tumor growth. Here are more details from data presented at the Europea
By Bhanvi Satija LONDON, Oct 23 (Reuters) – Swiss drugmaker Novartis’ drug Kisqali helped extend survival for women with a form of high-risk, early-stage breast cancer, cutting their risk of death by 19% after six years, according to trial data presented at the European Society for Medical Oncology
By Nancy Lapid Oct 23 (Reuters) – Today we shine a light on a study that suggests just how misguided and potentially dangerous new US hepatitis B vaccination guidelines may be for many infants. We also report on an analysis that should ease some concerns for pregnant women taking popular GLP-1 drugs
By Sahil Pandey Oct 23 (Reuters) – Zymeworks said on Friday Roche has gained rights to develop and commercialize its experimental lung cancer drug under a global licensing deal worth up to $813 million. • Zymeworks will receive $55 million upfront and an additional $40 million when the Swiss drugmak
By Rishika Sadam HYDERABAD, Oct 23 (Reuters) – Dr Reddy’s Laboratories has expanded its portfolio of generic versions of Ozempic with two new brands, according to product photographs and marketing materials reviewed by Reuters, after supply disruptions hit sales of its original Obeda injection in In
By Waylon Cunningham and Nicholas P. Brown Oct 23 (Reuters) – Protein-infused bottled water. Ice cream. Boxed macaroni and cheese. Even vodka. The rise of weight-loss drugs is driving a boom in protein-based products, as users of GLP-1 medication like Novo Nordisk’s Ozempic and Eli Lilly’s Mounjaro
Oct 23 (Reuters) – Smith & Nephew held merger talks with Johnson & Johnson to combine with the US group’s orthopaedics division but discussions collapsed after a disagreement over who would run the enlarged company, the Financial Times reported on Friday, citing people familiar with the matter. Merg
(Fixes dropped letter in name in paragraph 16) By Emma Rumney LONDON, Oct 23 (Reuters) – Heineken has urged British pubs and bars to adapt to the booming use of weight-loss drugs or risk losing customers and revenue, according to a company presentation seen by Reuters, in a rare acknowledgement from
Oct 22 (Reuters) – US biotech company Vor Bio said on Thursday its experimental kidney disease drug slowed the loss of kidney function and reduced the risk of disease progression in a late-stage study. The study included patients with IgA nephropathy, a disease that can eventually lead to kidney fai
By Sahil Pandey Oct 22 (Reuters) – Gilead Sciences said on Thursday it will acquire PepStar Therapeutics’ oral inflammation drug program, including an experimental bowel disease treatment, for $1.275 billion in cash upfront. The deal follows positive mid-stage results for Gilead’s experimental pill
By Kamal Choudhury Oct 22 (Reuters) – Moderna’s shares sank over 25% on Thursday as late-stage trial data for its personalized melanoma vaccine, developed with Merck, triggered what analysts called a “sell-the-news” reaction after a months-long stock surge. The selloff wiped out about $24 billion fr
By Michael Erman and Julie Steenhuysen Oct 22 (Reuters) – Moderna and Merck said on Thursday that their mRNA cancer vaccine when combined with Merck’s widely used immunotherapy cut the risk of melanoma death or recurrence by 42% in a large trial, potentially paving the way for a new era of personali
By Camillus Eboh ABUJA, Oct 22 (Reuters) – Nigeria’s health minister said on Thursday authorities had no evidence that the country’s recently confirmed Ebola case had spread into the wider community, describing it as a single, contained infection. Nigeria reported its first Ebola case in more than a
AI Knows When To Skip Medical Tests, Except Where Doctors Disagree, Israeli Study Finds By The Media Line Staff Artificial intelligence models rarely recommended unnecessary medical care in a new Israeli study, but their accuracy dropped sharply on tests that doctors themselves disagree over, resear
Families of Slain Hostages Demand Netanyahu Stop Using Their Deaths in Election Campaign By The Media Line Staff Families of 17 Israeli hostages who died or were killed in Gaza urged Prime Minister Benjamin Netanyahu and his Likud party Tuesday to stop presenting the return of hostages as an electio
PARIS, Oct 22 (Reuters) – France has reported the first known human case of Shamonda virus in a patient who died, raising questions about the risks posed by a livestock virus that has reached Europe this year decades after first being detected in Nigeria. WHAT IS SHAMONDA VIRUS? Shamonda is transmit
Oct 22 (Reuters) – UNICEF and Geneva-based global vaccine group Gavi said on Thursday that they have reached an agreement to cut the price of the Mosquirix malaria vaccine by about 40%. Here are more details: • The deal, executed by UNICEF and financially backed by Gavi, is expected to generate arou
By Olivia Le Poidevin GENEVA, Oct 22 (Reuters) – The World Health Organization said on Thursday it was unlikely that the first documented human case of the Shamonda virus disease, which is usually found in livestock, would spread further, adding that it was monitoring the situation. “Based on curren
By Christy Santhosh Oct 22 (Reuters) – AbbVie said on Thursday its experimental drug significantly reduced inflammatory lumps and abscesses in patients with a chronic skin disease, meeting the main goal of a late-stage study. AbbVie is betting on the drug, lutikizumab, to broaden its immunology fran
By Clement Bonnerot, Anait Miridzhanian and Robbie Corey-Boulet DAKAR, Oct 22 (Reuters) – The Ebola patient in Nigeria, the Ugandan-born wife of a Swiss diplomat based in Abuja, is believed to have contracted the disease while travelling in Uganda, a Swiss government statement to Reuters said on Thu
Oct 22 (Reuters) – Quest Diagnostics on Thursday said it learned of unauthorized access to its Quanum LSM system, which some clients use to place test orders, receive and look up results. The breach adds to a growing number of cyberattacks on the healthcare sector, including those on medical device
By Camillus Eboh, Clement Bonnerot and Jennifer Rigby ABUJA/DAKAR, Oct 22 (Reuters) – Nigeria’s first Ebola patient in over a decade was not tested for the disease until 13 days after falling ill, officials said, a delay that raises questions about authorities’ ability to contain an outbreak already
Oct 22 (Reuters) – Germany’s BioNTech said on Thursday it had teamed up with Gilead Sciences to test its experimental cancer therapy in combination with the US drugmaker’s approved treatment in patients with a form of advanced breast cancer. Here are some details: • The late-stage trial will test Bi
Oct 22 (Reuters) – Poland on Thursday committed to join a HealthAI-led global network for governing the use of artificial intelligence in healthcare, as Europe rolls out new AI rules amid growing concerns over unpredictable AI behaviour. • Poland would become the second European Union member state a
ZURICH, Oct 22 (Reuters) – Swiss skincare company Galderma raised its full-year sales guidance on Thursday for the second time in two quarters after strong demand for its therapeutic dermatology products drove robust growth in the first nine months of the year. The company reported net sales of $4.7
By Danielle Kaye and Alexander Marrow NEW YORK, Oct 22 (Reuters) – Lorraine Scott has spent at least $300 to tailor her pants and jeans since losing 60 pounds on weight-loss drugs over the past year. “Most of the things in my closet didn’t fit anymore,” she said. The 42-year-old Atlanta resident, wh
Oct 22 (Reuters) – Belgian-Dutch pharmaceutical firm argenx said on Thursday that global sales of its leading autoimmune drug Vyvgart rose 54% in the third quarter, as it reached more patients. Sales of Vyvgart, a prescription drug used to treat adults with generalized myasthenia gravis, an autoimmu
